| Year |
Citation |
Score |
| 2023 |
Choi JY, Noguchi Y, Alburger JM, Bayle S, Chung E, Grant W, Chaikuad A, Knapp S, Duckett DR, Roush WR. Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ. Journal of Medicinal Chemistry. PMID 37204207 DOI: 10.1021/acs.jmedchem.2c01180 |
0.407 |
|
| 2017 |
Monastyrskyi A, Nilchan N, Quereda V, Noguchi Y, Ruiz C, Grant W, Cameron M, Duckett D, Roush W. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer. Bioorganic & Medicinal Chemistry. PMID 29289448 DOI: 10.1016/J.Bmc.2017.12.020 |
0.468 |
|
| 2015 |
Rosenberg LH, Lafitte M, Quereda V, Grant W, Chen W, Bibian M, Noguchi Y, Fallahi M, Yang C, Chang JC, Roush WR, Cleveland JL, Duckett DR. Therapeutic targeting of casein kinase 1δ in breast cancer. Science Translational Medicine. 7: 318ra202. PMID 26676609 DOI: 10.1126/scitranslmed.aac8773 |
0.416 |
|
| 2015 |
Ghalei H, Schaub FX, Doherty JR, Noguchi Y, Roush WR, Cleveland JL, Stroupe ME, Karbstein K. Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth. The Journal of Cell Biology. 208: 745-59. PMID 25778921 DOI: 10.1083/Jcb.201409056 |
0.439 |
|
| 2013 |
Bibian M, Rahaim RJ, Choi JY, Noguchi Y, Schürer S, Chen W, Nakanishi S, Licht K, Rosenberg LH, Li L, Feng Y, Cameron MD, Duckett DR, Cleveland JL, Roush WR. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties. Bioorganic & Medicinal Chemistry Letters. 23: 4374-80. PMID 23787102 DOI: 10.1016/J.Bmcl.2013.05.075 |
0.459 |
|
| Show low-probability matches. |